Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events
Open Access
- 21 May 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 176, 37-42
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular DiseaseJAMA Cardiology, 2019
- Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trialsContemporary Clinical Trials, 2019
- Nonadherence to statins: individualized intervention strategies outside the pill boxVascular Health and Risk Management, 2018
- Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherencePLOS ONE, 2017
- National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013JAMA Cardiology, 2017
- Burden of First and Recurrent Cardiovascular Events Among Patients With HyperlipidemiaClinical Cardiology, 2015
- Prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) and Diabetes Populations in the United StatesJournal of Clinical Lipidology, 2015
- Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetesBMJ, 2010
- Joint Modeling and Estimation for Recurrent Event Processes and Failure Time DataJournal of the American Statistical Association, 2004
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996